Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions
Autoimmune hemolytic anemia (AIHA) is a rare disease in which autoantibodies target red blood cells (RBCs), leading to anemia that ranges from no symptoms to severe life-threatening hemolysis. Little is known about the severity of anemia, blood transfusion efficiency and risk of transfusion-related reactions among hospitalized AIHA patients, especially in those with incompatible RBC transfusions.
A retrospective study was conducted among hospitalized AIHA patients from January 2009 to December 2015 in a large tertiary care medical center in southwest China.
A total of 450 AIHA hospitalized patients were recruited, of whom 97.3% had warm AIHA, 30.3% had primary AIHA, and 90.7% were treated with corticosteroids. On admission, approximately 3% of patients had an hemoglobin (Hb)
Source: Medicine - Category: Internal Medicine Tags: Research Article: Observational Study Source Type: research
More News: Anemia | Autoimmune Disease | Blood Transusion | China Health | Corticosteroid Therapy | Internal Medicine | Rare Diseases | Study